FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/26/2025
Back to search
Official data from USPTO
CYTOPREVENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/27/2025
Classification
Registered
Trademark type
Combined
Nice classes
41, 42, 44
Filing date
07/15/2022
Registration date
11/05/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2024
Last transaction
04/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
34
Owner location
FR
Examiner
HUSSAIN, TASNEEM
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "CYTOPREVENT" on a cloud-shaped design.
Holders and representatives
Holders
VYGON SAS
Representatives
Nicholas D. Wells Legends Law Group, PLLC
Technical classification
Nice Classes
Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Organization and conducting of non-virtual in-person educational discussion forums in the field of healthcaretoxicologyhealthcare proceduresavoiding contamination risks from occupational exposure to hazardous drugs on healthcare professionals
Class 42
Providing information with respect to scientific mattersdrug screening for scientific research purposestoxicity and handling of cytotoxic materials
Class 44
Providing information with respect to medical mattersdrug use testing servicesmedical procedure protocolsmedical safety protocolsdrug dosage and use information and drug interaction information
Publications
History of USPTO decisions and trademark events.
31 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/05/2025
FIMP
FINAL DISPOSITION PROCESSED
04/05/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/05/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/20/2024
PUBO
PUBLISHED FOR OPPOSITION
08/20/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/31/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/16/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/30/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/19/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/19/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/19/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/07/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/07/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/20/2023
GNFR
FINAL REFUSAL E-MAILED
12/20/2023
CNFR
FINAL REFUSAL WRITTEN
12/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/07/2023
RFNT
REFUSAL PROCESSED BY IB
07/05/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/14/2023
RFRR
REFUSAL PROCESSED BY MPU
06/14/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/05/2023
CNRT
NON-FINAL ACTION WRITTEN
05/04/2023
DOCK
ASSIGNED TO EXAMINER
05/02/2023
MAFR
APPLICATION FILING RECEIPT MAILED
01/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/30/2022
Continuous trademark protection
Get notified about every new filing that threatens CYTOPREVENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.